Medindia
Medindia LOGIN REGISTER
Advertisement

Bio-Identical Hormone Menopause Doctor Responds to Outrageous FDA News

Saturday, January 12, 2008 General News
Advertisement
SPOKANE, Wash., Jan. 11 "The FDA statement regardingcompounded estrogens -- which include estradiol and estriol -- progesterone,and other compounded hormones was very surprising to me and other medicalexperts in the field of Women's Hormones," remarks Cheryle Hart, M.D. She isMayo Clinic trained and Board certified in Ob/Gyn and founded what is nowHormones by Hart in 1997. She is also the medical director of Hormones byHart.
Advertisement

The FDA stated on January 9, 2008 that pharmacies cannot use the term"bio-identical" to describe the hormones they are compounding. "Even thoughthe hormones they are using are actually chemically identical to what isproduced by the human body," says Dr. Hart.
Advertisement

"I am astounded that the FDA does not recognize that estradiol,progesterone, testosterone, and DHEA are chemically identical to hormonesfound in our bodies, and are therefore bio-identical. I don't know what'substantial evidence' they are waiting for to figure that one out."

According to their news release, the FDA does not approve of the use ofthe estrogen estriol in any compounded formula. They consider this themanufacture of an unapproved drug. "This is certainly news to me, sinceestriol is one of the types of hormones naturally found in a woman's body. Forthe FDA to say that menopausal women cannot benefit from the use of Estriol inHRT amazes me. I would certainly like the FDA to reconsider the publishedevidence on this estrogen and change their ruling," comments Dr. Hart.

Because of the misleading title of the FDA News release, Dr. Hart wants toreassure her patients that while it sounds like FDA is banning compoundedbio-identical hormones, it is not banning the compounded hormones.

"It is really up to the compounding pharmacies and their organizations,PCCA and IACP to get this straightened out with the FDA. Since the FDA's newposition is that compounds containing estriol represent a 'new drug' it wouldbe improper for me or any other medical practitioner to continue to prescribeEstriol compounds at this time," says Cheryle Hart, M.D.

SOURCE Cheryle R. Hart, M.D.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close